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INTRODUCTION
The generation of desired functional cell types is a long-standing goal of regenerative medicine, and one that holds great promise for biomedical applications, notably in transplantation procedures. For example, liver transplantation is a successful treatment but because of a lack of donor livers it is calculated that 18% of adults in the UK listed for liver transplantation will die before livers become available, and artificially induced liver cells could be used for such therapeutic transplantation. Conventional strategies, particularly the directed differentiation of pluripotent stem cells, have been widely studied for this purpose, and effective procedures have been developed [1] . Embryonic stem cells are derived from blastocysts and so are pluripotent. They are non-transformed cells and can proliferate extensively when cultured on irradiated or mitomycin-treated fibroblast feeder layers together with leukemia inhibitory factor (LIF) or bFGF. They can be differentiated into derivatives of all three germ layers. However, ethical problems and teratoma formation hamper their widespread clinical application. Induced pluripotent stem cells (iPSCs) are another type of pluripotent stem cell derived from mouse and human somatic cells by overexpressing combinations of transcription factors (e.g. Oct-4, SOX2, Klf4, and c-Myc) [2] . They can also be differentiated into any cell type originating in the three embryonic germ layers. Although there are little or no ethical problems associated with their use, they, like embryonic stem cells they can produce tumors [3] .
Compared to such pluripotent stem cells, directly reprogrammed cells have a low potential for tumor formation and can be reprogrammed into the desired cell types rapidly and efficiently.
A strategy for reprogramming using transcription factor was first described in the case of MyoD [4] . The innovated discovery of iPSCs proved that combinations of cell specific transcription factors could alter cell fate [2] . This strategy has been applied to lineage reprogramming, and direct reprogramming has been used to obtain neural cells, cardiomyocytes, hepatocytes, and pancreatic cells [5] [6] [7] [8] . In this review we will outline the history of direct reprogramming and discuss recent progress (Tables 1,2 ). We will also consider future challenges and therapeutic applications. The direct reprogramming of a terminally differentiated cell into another lineage using defined combinations of factors has fundamentally changed traditional concepts of the inalterability of differentiated cells. Many studies have achieved direct conversion into various cell types in recent years, and this strategy is considered to be a promising approach for inducing functional cells. Here, we review work on direct reprogramming, from the early pioneering studies to the most recent, including the discovery of novel reprogramming factors, molecular mechanisms, and strategies. We also discuss the applications of direct reprogramming and the perspectives and challenges of this novel technology.
HISTORY OF REPROGRAMMING TECHNOLOGY
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Hanyang Med Rev 2015;35:215-221 nucleus of a fully differentiated cell into an enucleated frog egg could reprogram the cell and lead to the regeneration of an entire frog [9] . This research led to the cloning of mammals like Dolly the Sheep by somatic nuclear transfer [10] . In 1987, Weintraub and collaborators demonstrated that a single cell-type-specific transcription factor, MyoD, could act as a master switch inducing fibroblasts to form skeletal muscle cells [4] . This finding suggested that MyoD played a key role in myogenesis and muscle development [11] . Subsequent studies demonstrated that transcription factor-driven cell fate conversion could be achieved between related lineages such as blood, endoderm, and nervous system cells [12- [15] [16] [17] . Likewise, other cell sources such as neural stem cells, liver and stomach cells, and terminally differentiated blood cells, can be reprogrammed into iPSCs by the same factors [18] [19] [20] and iPSCs can be induced by other combinations of transcriptional factors such as Nanog, Lin28, ESRRB, NR-5A2 that play core roles in development [17, 21] . The breakthrough production of iPSCs attracted interest in the further challenge of converting mature cells directly into other types by overexpressing lineage specific transcriptional factors and bypassing the stem cell state [5, 7, 22] . Recently, many studies have described direct reprogramming generating cell types such as neural cells, cardiomyocytes, hepatocytes and pancreatic β cell [5] [6] [7] [8] .
DIRECT REPROGRAMMING TO FORM NEURAL CELLS
It seems quite a challenge to induce one cell type directly from one of another lineage. Direct reprogramming of fibroblasts into neurons was first achieved using 19 candidate genes [7] . After continuous elimination of genes, three genes, Ascl1, Brn2, and Myt1l, were found to be the minimal neuron-specific factors for lineage reprogramming of fibroblasts into neural cells. The induced neuronal cells produced spontaneous action potentials, expressed multiple neuron-specific proteins and were able to form functional and miR-124 [27] , and Axl1, Myt1l, neuroD2, miR-9/9 and mmiR-124 [28] . Dopaminergic neurons could be induced to form from human fibroblasts by the combination of Asxl1, Lmx1a, and Nurr1 [29] . Similarly, human fibroblasts could be converted into motor neurons by Asc1l, Brn2, Myt1l, Lhx2, Hb9, Isl1, and Ngn2 [23] .
These studies were the first to demonstrate that direct lineage reprogramming is not limited to the same germ layer or lineage system, since fibroblasts, which are derived from mesoderm, could be converted into neurons, which are of ectodermal origin.
DIRECT REPROGRAMMING INTO CARDIOMYOCYTES
Although embryonic mesoderm cells could be induced to differentiate into cardiomyocytes, the master genes of cardiac differentiation had not been identified, despite much research influenced by the identification of MyoD [4, 30] . Fourteen candidate factors were initially selected as able to induce cardiomyocyte-like cells [31] . Then by knockout studies in mice, the requirements were narrowed down to the minimal set of Gata4, Mef2c, and Tbx5.
However, the transcriptome of the induced cardiomyocyte-like cells differed from that of neonatal cardiomyocytes and only a small percentage of the cells were able to contract. Subsequently two groups reported that retroviral delivery of the combination of Gata4, Mef2c, and Tbx5 could convert fibroblasts into cardiomyocytes at sites of infarction and decrease injury size [32] . Another study demonstrated that direct conversion into cardiomyocytes was more efficient when the transcription factors Hand2 was added, in both an in vitro and in an in vivo myocardial infarction model [33] . A different group found that the combination of Tbx5, Mef3c, and myocardin could induce a wider spectrum of myocardial genes than previous combinations [34] . A subsequent study showed that fibroblasts could be converted into cardiomyocytes by microRNAs in the combination miR-1, miR-133, miR-208, miR-499, and JAK inhibitor both in vitro and in vivo [35] . Another group looked for robust calcium oscillations and spontaneous beating and concluded that the combination of Hand2, Nkx2-5, Gata4, Mef3x, and Tbx5 was the most effective inducer [36] . 
DIRECT REPROGRAMMING TO HEPATOCYTE CELL TYPE
It is now accepted that terminally differentiated cell types can undergo direct transdifferentiated into cells of other lineages in response to overexpressing lineage-specific factors but it is not always clear whether the transdifferentiated cells can function in damaged organs when transplanted. Two groups have shown that hepatocytes induced from fibroblasts can improve the function of injured hepatic tissues after transplantation [5, 6] . Hepatocytes induced by a combination of Gata4, Hnf1a, and Foxa3 and inactivation of p19Arf expressed hepatic genes and restored the function of damaged livers in mice [5] . The hepatocytes in another study were generated by Hnf4a plus Foxa1, Foxa2, or Foxa3 and also had several hepatocyte-specific features, and their transplantation rescued damaged hepatic tissues [6] . Two further studies demonstrated direct reprogramming of fibroblasts into human hepatocytes.
The combination of HNF4 (instead of GATA4), HNF1A, and FO-XA3 converted human fibroblasts into induced hepatocytes [37] and the same study showed that hepatocytes induced by overexpressing SV40 large T antigen could be grown in vitro. Another group used a combination of HNF1A, HNF4A, HNF6, CEBPA, ATF5, and PROX1 together with overexpression of c-Myc and knockdown of p53 for reprogramming [38] . This combination had the advantage of avoiding forced proliferation of mature cells, which could cause some damage. In both cases, the human induced he- cells that can control blood sugar levels by producing insulin [39] and the ability to produce insulin was considerably enhanced when Pdx1 was fused with the VP16 transcriptional activation domain (Pdx1/VP16) [40] . As a result, adenoviral transfection of PDX1 reprogrammed hepatocytes into cells decreased blood glucose levels in DM animal models [41] . Likewise, delivery of Ngn3, MafA, and 
STRATEGIES FOR PRODUCING LARGE NUMBERS OF INDUCED CELLS FOR TRANSLATIONAL PURPOSES
Like iPSC technology, lineage reprogramming can be used in biomedical applications, including disease modeling, cell therapy and drug testing [3] . However the direct reprogramming strategy has the theoretical advantages of shortening the time needed for reprogramming and minimizing the risk of teratoma formation. [43, 44] , oligodendrocyte precursor cells [45] , hepatic stem cells [46] , HSCs [47] , and hematopoietic multipotent progenitors [48] . Another approach is to induce transient expandable intermediates during lineage differentiation. This strategy has been used for producing human hepatocytes [38] .
TRANSLATION OF LINEAGE REPROGRAMMING FOR CELL THERAPY
Undoubtedly 
